New York, New York-- (Newsfile Corp. - January 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...
Zacks.com on MSN5d
TMDX Stock Plunges 49.2% in Three Months: What's Behind the Downfall?TransMedics is navigating macroeconomic challenges amid its focus on meaningful progress across each of its growth initiatives.
NEW YORK CITY, NY / ACCESS Newswire / January 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
Headwaters Capital Management, an investment management company, released its fourth-quarter 2024 investor letter. A copy of ...
Zacks.com on MSN8d
TMDX Stock Down Despite Responding to Misleading Short-Seller ReportTransMedics Group, Inc. TMDX recently issued a statement refuting the claims made in a report by short-seller Scorpion ...
Shares of organ transplant innovator TransMedics Group (NASDAQ: TMDX) fell 15.7% through Thursday trading, according to data ...
TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...
TransMedics Gr TMDX has outperformed the market over the past 5 years by 12.34% on an annualized basis producing an average ...
JP Morgan has recently reduced TransMedics Group Inc (TMDX) stock to Neutral rating, as announced on December 17, 2024, according to Finviz. Earlier, on November 22, 2024, Needham had reduced the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
January 18, 2025, 05:16 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback